BIO-PATH HOLDINGS, INC. Files 8-K Report
Ticker: BPTH · Form: 8-K · Filed: Apr 18, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, financials
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K. Check for updates on financials and events.
AI Summary
On April 18, 2024, BIO-PATH HOLDINGS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided text excerpt.
Why It Matters
This filing serves as an official notification to the SEC and investors about significant company events or financial updates. It provides transparency regarding the company's operational and financial status.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific material events or financial data that would indicate immediate risk.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- 0001558370-24-005280 (other) — Accession Number
- April 18, 2024 (date) — Report Date
- Delaware (location) — State of Incorporation
- 001-36333 (other) — Commission File Number
- 87-0652870 (other) — IRS Employer Identification No.
- 4710 Bellaire Boulevard , Suite 210 , Bellaire , Texas 77401 (address) — Principal Executive Offices
FAQ
What specific "Other Events" are reported by BIO-PATH HOLDINGS, INC. in this 8-K filing?
The provided text excerpt does not detail the specific "Other Events" beyond listing the item information category.
What are the "Financial Statements and Exhibits" being filed by BIO-PATH HOLDINGS, INC.?
The excerpt lists "Financial Statements and Exhibits" as an item information category but does not specify the content of these statements or exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 18, 2024, as indicated by the 'Date of earliest event reported'.
What is BIO-PATH HOLDINGS, INC.'s principal executive office address?
BIO-PATH HOLDINGS, INC.'s principal executive office is located at 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
What is the SIC code for BIO-PATH HOLDINGS, INC.?
The Standard Industrial Classification (SIC) code for BIO-PATH HOLDINGS, INC. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 444 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2024-04-18 09:13:06
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20240418x8k.htm (8-K) — 38KB
- bpth-20240418xex99d1.htm (EX-99.1) — 18KB
- bpth-20240418xex99d1001.jpg (GRAPHIC) — 11KB
- 0001558370-24-005280.txt ( ) — 194KB
- bpth-20240418.xsd (EX-101.SCH) — 3KB
- bpth-20240418_lab.xml (EX-101.LAB) — 16KB
- bpth-20240418_pre.xml (EX-101.PRE) — 10KB
- bpth-20240418x8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On April 18, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release titled, "Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients." A copy of such press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated April 18, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: April 18, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer